Cell and gene therapy landscape in respiratory diseases and future outlook
This trend has led to the development of CGTs shifting from the US and EU to APAC.
Cell & Gene Therapy
Centenarians – unlocking the secrets of living to 100
MeiraGTx’s Parkinson’s gene therapy shows promise in Phase I/II study
Terumo and Charles River demonstrate effectiveness of CGT manufacturing device
Advancing quality control measures vital for cell and gene therapy development
NHS investment critical to drive cell and gene therapy research
Gene therapy for rare neuropathy displays potential in NIH trial
Can Gilead shake up the ASCT-ineligible large B-cell lymphoma market?
